Infectious diseases in the Arabian Peninsula and Egypt

Clinical Microbiology and Infection

Volumn 18, Issue 11, 2012, Pages 1068-1080

  Shibl, A ^a,b   Senok, A ^a   Memish, Z ^a,c  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

Alkhurma; Antibiotic resistance; Arabian Peninsula; Dengue; Hepatitis C; HIV; Malaria; Mass gatherings; Tuberculosis

Indexed keywords

CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ALKHURMA HAEMORRHAGIC FEVER VIRUS; ANTIBIOTIC RESISTANCE; ASIA; BACTERIAL INFECTION; DENGUE; EGYPT; EPIDEMIC; HEMORRHAGIC FEVER; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; PARASITOSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION;

EID: 84867670542     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12010     Document Type: Review

References (140)

1. WHO report 2011, Global Tuberculosis Control. Available at: http://www.who.int/tb/publications/global_report/en/ (last accessed 25 June 2012).
2. Ahmad S, Fares E. Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. Med Princ Pract 2005; 14: 16-21.
3. Al-Hajoj SA. Tuberculosis in Saudi Arabia: can we change the way we deal with the disease? J Infect Public Health 2010; 3: 17-24.
4. Al-Maniri A, Fochsen G, Al-Rawas O, De Costa A. Immigrants and health system challenges to TB control in Oman. BMC Health Serv Res 2010; 10: 210.
5. Gleason JA, McNabb SJ, Abduljadayel N, Abouzeid MS, Memish ZA. Tuberculosis trends in the kingdom of Saudi Arabia, 2005-2009. Ann Epidemiol 2012; 22: 264-269.
6. Abouzeid MS, Zumla AI, Felemban S, Alotaibi B, O'Grady J, Memish Z. Tuberculosis trends in Saudis and non-Saudis in the kingdom of Saudi Arabia-a 10 year retrospective study (2000-2009). PLoS ONE 2012; 7: e39478.
7. Al-Maniri A, Singh JP, Al-Rawas O et al. A snapshot of the biodiversity and clustering of Mycobacterium tuberculosis in Oman using spoligotyping. Int J Tuberc Lung Dis 2010; 14: 994-1000.
8. Ahmad S, Mokaddas E. The occurrence of rare rpob mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005; 26: 205-212.
9. Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents 2001; 17: 415-418.
10. Al-Hajoj SA, Zozio T, Al-Rabiah F et al. First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia. J Clin Microbiol 2007; 45: 2467-2473.
11. Varghese B, Hillemann A, Wijayanti DR et al. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia. Infect Genet Evol 2012; 12: 549-556.
12. Al-Zarouni M, Dash N, Al Ali M, Al-Shehhi F, Panigrahi D. Tuberculosis and MDR-TB in the northern emirates of United Arab Emirates: a 5-year study. Southeast Asian J Trop Med Public Health 2010; 41: 163-168.
13. Mokaddas E, Ahmad S, Samir I. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005. Int J Tuberc Lung Dis 2008; 12: 319-325.
14. Al-Akhali A, Ohkado A, Fujiki A et al. Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004. Int J Tuberc Lung Dis 2007; 11: 1328-1333.
15. Abbadi S, Rashed HG, Morlock GP, Woodley CL, El Shanawy O, Cooksey RC. Characterization of IS 6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. J Clin Microbiol 2001; 39: 2330-2334.
16. Abbadi SH, Sameaa GA, Morlock G, Cooksey RC. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Int J Infect Dis 2009; 13: 673-678.
17. Abu-Raddad LJ, Hilmi N, Mumtaz G et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010; 24 (suppl 2): S5-S23.
18. Badahdah AM. Stigmatization of persons with HIV/AIDS in Saudi Arabia. J Transcult Nurs 2010; 21: 386-392.
19. Badahdah AM, Foote CE. Role of shame in the stigmatization of people with human immunodeficiency virus: a survey of female college students in 3 Arab countries. East Mediterr Health J 2010; 16: 982-987.
20. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Al Huzaim NS. Epidemiology of the human immunodeficiency virus in Saudi Arabia; 18-year surveillance results and prevention from an Islamic perspective. BMC Infect Dis 2004; 4: 25.
21. Al-Mazrou YY, Al-Jeffri MH, Fidail AI, Al-Huzaim N, El-Gizouli SE. HIV/AIDS epidemic features and trends in Saudi Arabia. Ann Saudi Med 2005; 25: 100-104.
22. Alzahrani AJ. Analysis of HIV subtypes and the phylogenetic tree in HIV-positive samples from Saudi Arabia. Saudi Med J 2008; 29: 1394-1396.
23. Badreddine S, Smith K, van Zyl H et al. Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found. AIDS Res Hum Retroviruses 2007; 23: 667-674.
24. Jamjoom GA, Azhar EI, Madani TA, Hindawi SI, Bakhsh HA, Damanhouri GA. Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia. Saudi Med J 2010; 31: 987-992.
25. al-Haddad MK, Baig BZ, Ebrahim RA. Epidemiology of HIV and AIDs in Bahrain. J Commun Dis 1997; 29: 321-328.
26. Husain E, Grover SB, Mujaibel K, Al-Owayish R, Anwar S. The need for routine antenatal HIV screening for pregnant women in Kuwait. Med Princ Pract 2005; 14: 208.
27. Barss P, Grivna M, Ganczak M et al. Effects of a rapid peer-based HIV/AIDS educational intervention on knowledge and attitudes of high school students in a high-income Arab country. J Acquir Immune Defic Syndr 2009; 52: 86-98.
28. World Health Organization. World malaria report 2011. Available at: http://www.who.int/malaria/world_malaria_report_2011/en/ (last accessed 25 June 2012).
29. Ismaeel AY, Senok AC, Jassim Al-Khaja KA, Botta GA. Status of malaria in the Kingdom of Bahrain: a 10-year review. J Travel Med 2004; 11: 97-101.
30. Dar FK, Bayoumi R, al Karmi T, Shalabi A, Beidas F, Hussein MM. Status of imported malaria in a control zone of the United Arab Emirates bordering an area of unstable malaria. Trans R Soc Trop Med Hyg 1993; 87: 617-619.
31. Nerlich AG, Schraut B, Dittrich S, Jelinek T, Zink AR. Plasmodium falciparum in ancient Egypt. Emerg Infect Dis 2008; 14: 1317-1319.
32. Dahesh SM, Bassiouny HK, El-Masry SA. Malariometric parasitological survey in El-Fayoum governorate, Egypt. J Egypt Soc Parasitol 2009; 39: 213-225.
33. Hassan AN, Kenawy MA, Kamal H, Abdel Sattar AA, Sowilem MM. GIS-based prediction of malaria risk in Egypt. East Mediterr Health J 2003; 9: 548-558.
34. Al-Mekhlafi AM, Al-Mekhlafi HM, Mahdy MA, Azazy AA, Fong MY. Human malaria in the highlands of Yemen. Ann Trop Med Parasitol 2011; 105: 187-195.
35. Al-Taiar A, Jaffar S, Assabri A et al. Severe malaria in children in Yemen: two site observational study. BMJ 2006; 333: 827-830.
36. The global burden of disease: 2004 update. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (last accessed 25 June 2012).
37. Gubler DJ. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. Wallingford, UK: CAB International, 1997.
38. Jimenez-Lucho VE, Fisher EJ, Saravolatz LD. Dengue with hemorrhagic manifestations: an imported case from the Middle East. Am J Trop Med Hyg 1984; 33: 650-653.
39. Fakeeh M, Zaki AM. Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994-1999. Am J Trop Med Hyg 2001; 65: 764-767.
40. Zaki A, Perera D, Jahan SS, Cardosa MJ. Phylogeny of dengue viruses circulating in Jeddah, Saudi Arabia: 1994-2006. Trop Med Int Health 2008; 13: 584-592.
41. Dengue: guidelines for diagnosis, treatment, prevention and control. New Edition 2009. Available 25 at: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf (last accessed 25 June 2012).
42. Burdino E, Milia MG, Sergi G et al. Diagnosis of dengue fever in north West Italy in travelers from endemic areas: a retrospective study. J Clin Virol 2011; 51: 259-263.
43. Ravanini P, Huhtamo E, Hasu E et al. Imported dengue virus serotype 3, Yemen to Italy, 2010. Emerg Infect Dis 2011; 17: 929-931.
44. Zaki AM. Isolation of a flavivirus related to the tick-borne encephalitis complex from human cases in Saudi Arabia. Trans R Soc Trop Med Hyg 1997; 91: 179-181.
45. Charrel RN, Zaki AM, Fakeeh M et al. Low diversity of Alkhurma hemorrhagic fever virus, Saudi Arabia, 1994-1999. Emerg Infect Dis 2005; 11: 683-688.
46. Charrel RN, Zaki AM, Attoui H et al. Complete coding sequence of the Alkhurma virus, a tick-borne flavivirus causing severe hemorrhagic fever in humans in Saudi Arabia. Biochem Biophys Res Commun 2001; 287: 455-461.
47. Madani TA. Alkhumra virus infection, a new viral hemorrhagic fever in Saudi Arabia. J Infect 2005; 51: 91-97.
48. Alzahrani AG, Al Shaiban HM, Al Mazroa MA et al. Alkhurma hemorrhagic fever in humans, Najran, Saudi Arabia. Emerg Infect Dis 2010; 16: 1882-1888.
49. Madani TA, Azhar EI, Abuelzein el TM et al. Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. J Infect 2011; 62: 67-76.
50. Memish ZA, Albarrak A, Almazroa MA et al. Seroprevalence of Alkhurma and other hemorrhagic fever viruses, Saudi Arabia. Emerg Infect Dis 2011; 17: 2316-2318.
51. Memish ZA, Charrel RN, Zaki AM, Fagbo SF. Alkhurma haemorrhagic fever-a viral haemorrhagic disease unique to the Arabian Peninsula. Int J Antimicrob Agents 2010; 36 (suppl 1): S53-S57.
52. Carletti F, Castilletti C, Di Caro A et al. Alkhurma hemorrhagic fever in travelers returning from Egypt, 2010. Emerg Infect Dis 2010; 16: 1979-1982.
53. Ravanini P, Hasu E, Huhtamo E et al. Rhabdomyolysis and severe muscular weakness in a traveler diagnosed with Alkhurma hemorrhagic fever virus infection. J Clin Virol 2011; 52: 254-256.
54. El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health and Population, 2009.
55. Yahia M. Global health: a uniquely Egyptian epidemic. Nature 2011; 474: S12-S13.
56. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA 2010; 107: 14757-14762.
57. Barakat SH, El-Bashir N. Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors. J Viral Hepat 2011; 18: 779-784.
58. Medhat A, Shehata M, Magder LS et al. Hepatitis C in a community in upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002; 66: 633-638.
59. Antaki N, Craxi A, Kamal S et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int 2010; 30: 342-355.
60. Kamal SM, Nasser IA. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 2008; 47: 1371-1383.
61. Esmat G, Hashem M, El-Raziky M et al. Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children. Liver Int 2012; 32: 449-456.
62. Arafa N, El Hoseiny M, Rekacewicz C et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005; 43: 418-424.
63. Abdelwahab S, Rewisha E, Hashem M et al. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Trans R Soc Trop Med Hyg 2012; 106: 98-103.
64. Fallahian F, Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl 2011; 22: 1-9.
65. al-Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection 1993; 21: 164-167.
66. Bener A, Al-Kaabi S, Derbala M, Al-Marri A, Rikabi A. The epidemiology of viral hepatitis in Qatar. Saudi J Kidney Dis Transpl 2009; 20: 300-306.
67. Alfaresi MS. Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients. Mol Biol Rep 2011; 38: 2719-2722.
68. Chehadeh W, Kurien SS, Abdella N et al. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. J Infect Public Health 2011; 4: 200-206.
69. Osoba AO. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J 2002; 23: 7-12.
70. Abro AH, Al-Dabal L, Younis NJ. Distribution of hepatitis C virus genotypes in Dubai, United Arab Emirates. J Pak Med Assoc 2010; 60: 987-990.
71. Shibl A, Memish Z, Pelton S. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents 2009; 33: 410.e411-410.e419.
72. Shibl AM. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Clin Microbiol Infect 2008; 14: 876-879.
73. Wasfy MO, Pimentel G, Abdel-Maksoud M et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother 2005; 55: 958-964.
74. Mokaddas EM, Rotimi VO, Albert MJ. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 2008; 15: 203-207.
75. Senok A, Al-Zarouni M, Al-Najjar J, Nublusi A, Panigrahi D. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006. J Infect Dev Ctries 2007; 1: 296-302.
76. Al Khorasani A, Banajeh S. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study. J Infect 2006; 53: 228-234.
77. Livermore DM, Canton R, Gniadkowski M et al. CTX-M: changing the face of ESBLS in Europe. J Antimicrob Chemother 2007; 59: 165-174.
78. Shakil S, Azhar EI, Tabrez S et al. New Delhi metallo-beta-lactamase (NDM-1): an update. J Chemother 2011; 23: 263-265.
79. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007; 28: 1114-1116.
80. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 2009; 3: 295-299.
81. Al-Zarouni M, Senok A, Al-Zarooni N, Al Nassay F, Panigrahi D. Extended spectrum beta lactamase-producing Enterobacteriaceae: in-vitro susceptibility to fosfosmycin, nitrofurantoin and tigecycline. Med Princ Pract 2012 [Epub ahead of print] DOI: 10.1159/000339200.
82. Al Sweih N, Salama MF, Jamal W, Al Hashem G, Rotimi VO. An outbreak of CTX-M-15-producing Klebsiella pneumoniae isolates in an intensive care unit of a teaching hospital in Kuwait. Indian J Med Microbiol 2011; 29: 130-135.
83. Bindayna KM, Senok AC, Jamsheer AE. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2009; 2: 129-135.
84. Alfaresi MS, Elkoush AA, Alshehhi HM, Abdulsalam AI. Molecular characterization and epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in the United Arab Emirates. Med Princ Pract 2011; 20: 177-180.
85. Al Hashem G, Al Sweih N, Jamal W, Rotimi VO. Sequence analysis of bla(CTX-M) genes carried by clinically significant Escherichia coli isolates in Kuwait hospitals. Med Princ Pract 2011; 20: 213-219.
86. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I. First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 2006; 27: 545-548.
87. Ahmed SH, Daef EA, Badary MS, Mahmoud MA, Abd-Elsayed AA. Nosocomial blood stream infection in intensive care units at Assiut university hospitals (upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms. BMC Res Notes 2009; 2: 76.
88. Fam N, Leflon-Guibout V, Fouad S et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 2011; 17: 67-73.
89. Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 2009; 29: 253-257.
90. Bindayna K, Khanfar HS, Senok AC, Botta GA. Predominance of CTX-M genotype among extended spectrum beta lactamase isolates in a tertiary hospital in Saudi Arabia. Saudi Med J 2010; 31: 859-863.
91. Shibl AM, Al-Agamy MH, Khubnani H, Senok AC, Tawfik AF, Livermore DM. High prevalence of acquired quinolone-resistance genes among enterobacteriaceae from Saudi Arabia with CTX-M-15 beta-lactamase. Diagn Microbiol Infect Dis 2012; 2010; 73: 350-353.
92. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007; 60: 394-397.
93. Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-5054.
94. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011; 19: 588-595.
95. Poirel L, Al Maskari Z, Al Rashdi F, Bernabeu S, Nordmann P. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 2011; 66: 304-306.
96. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in the Sultanate of Oman. Clin Microbiol Infect 2012; 18: E144-E148.
97. Jamal W, Rotimi VO, Albert MJ, Khodakhast F, Udo EE, Poirel L. Emergence of nosocomial New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int J Antimicrob Agents 2012; 39: 183-184.
98. Ghazawi A, Sonnevend A, Bonnin RA et al. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect 2012; 18: E34-E36.
99. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 2011; 66: 1260-1262.
100. Hrabak J, Stolbova M, Studentova V, Fridrichova M, Chudackova E, Zemlickova H. NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011. Euro Surveill 2012; 17: 1-3.
101. Panhotra BR, Saxena AK, Al-Ghamdi AM. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome. Saudi Med J 2004; 25: 1871-1876.
102. Bouchillon SK, Johnson BM, Hoban DJ et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 2004; 24: 119-124.
103. Kader AA, Kumar AK. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 2004; 25: 570-574.
104. Kader AA, Angamuthu K. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern province, Saudi Arabia. Saudi Med J 2005; 26: 956-959.
105. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 2005; 25: 239-242.
106. El-Khizzi NA, Bakheshwain SM. Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 2006; 27: 37-40.
107. Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet Oel S. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces hospital in Saudi Arabia. J Coll Physicians Surg Pak 2009; 19: 264-265.
108. Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al Hashim G. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the Vitek 2 and Etest systems in a Kuwait teaching hospital. Med Princ Pract 2005; 14: 325-331.
109. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO. The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 2008; 20: 445-451.
110. Al Benwan K, Al Sweih N, Rotimi VO. Etiology and antibiotic susceptibility patterns of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait. Med Princ Pract 2010; 19: 440-446.
111. Al Muharrmi Z, Rafay AM, Balkhair A, Al-Tamemi S, Al Mawali A, Al Sadiri H. Extended-spectrum beta-lactamase (ESBL) in Omani children: study of prevalence, risk factors and clinical outcomes at Sultan Qaboos university hospital, Sultanate of Oman. Sultan Qaboos Univ Med J 2008; 8: 171-177.
112. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 2008; 17: 32-36.
113. Abdel-Hady H, Hawas S, El-Daker M, El-Kady R. Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 2008; 28: 685-690.
114. Zaki Mel S. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a 2-year experience. J Infect Dev Ctries 2007; 1: 269-274.
115. Madani TA. Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the university hospital, Jeddah, Saudi Arabia. Can J Infect Dis 2002; 13: 245-250.
116. Baddour MM, Abuelkheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob 2006; 5: 30.
117. Asghar AH, Momenah AM. Methicillin resistance among Staphylococcus aureus isolates from Saudi hospitals. Med Princ Pract 2006; 15: 52-55.
118. Bukharie HA, Abdelhadi MS. The epidemiology of methicillin-resistant Staphylococcus aureus at a Saudi university hospital. Microb Drug Resist 2001; 7: 413-416.
119. Balkhy HH, Memish ZA, Almuneef MA et al. Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol 2007; 28: 976-982.
120. Al-Tawfiq JA. Incidence and epidemiology of methicillin-resistant Staphylococcus aureus infection in a Saudi Arabian hospital, 1999-2003. Infect Control Hosp Epidemiol 2006; 27: 1137-1139.
121. Bukharie HA. Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus. Am J Med Sci 2010; 340: 378-381.
122. Alsubaie S, Bahkali K, Somily AM et al. Nosocomial transmission of community-acquired methicillin-resistant Staphylococcus aureus in a well-infant nursery of a teaching hospital. Pediatr Int 2012. DOI: 10.1111/j1442-200x.2012.03673.x.
123. Bukhari EE, Al-Otaibi FE. Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children. Saudi Med J 2009; 30: 1595-1600.
124. Udo EE, Al-Sweih N, Dhar R et al. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals. Med Princ Pract 2008; 17: 71-75.
125. Prasanna M, Thomas C. A profile of methicillin resistant Staphylococcus aureus infection in the burn center of the Sultanate of Oman. Burns 1998; 24: 631-636.
126. Sonnevend A, Blair I, Alkaabi M et al. Change in meticillin-resistant Staphylococcus aureus clones at a tertiary care hospital in the United Arab Emirates over a 5-year period. J Clin Pathol 2012; 65: 178-182.
127. Sharaf EJ, Senok AC, Udo EE, Botta GA. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci. Med Princ Pract 2011; 20: 253-258.
128. Khan FY, Elshafie SS, Almaslamani M et al. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a 1 year hospital-based study. Travel Med Infect Dis 2010; 8: 377-387.
129. Borg MA, de Kraker M, Scicluna E et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007; 60: 1310-1315.
130. Saied GM. Microbial pattern and antimicrobial resistance, a surgeon's perspective: retrospective study in surgical wards and seven intensive-care units in two university hospitals in Cairo, Egypt. Dermatology 2006; 212 (suppl 1): 8-14.
131. Al-Obeid S, Haddad Q, Cherkaoui A, Schrenzel J, Francois P. First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. J Clin Microbiol 2010; 48: 2199-2204.
132. Udo EE, Al-Sweih N, Mohanakrishnan S, West PW. Antibacterial resistance and molecular typing of methicillin-resistant Staphylococcus aureus in a Kuwaiti general hospital. Med Princ Pract 2006; 15: 39-45.
133. Cirlan M, Saad M, Coman G et al. International spread of major clones of methicillin resistant Staphylococcus aureus: nosocomial endemicity of multilocus sequence type 239 in Saudi Arabia and Romania. Infect Genet Evol 2005; 5: 335-339.
134. Udo EE, O'Brien FG, Al-Sweih N, Noronha B, Matthew B, Grubb WB. Genetic lineages of community-associated methicillin-resistant Staphylococcus aureus in Kuwait hospitals. J Clin Microbiol 2008; 46: 3514-3516.
135. Udo EE, Sarkhoo E. The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals. Ann Clin Microbiol Antimicrob 2010; 9: 31.
136. Enany S, Yaoita E, Yoshida Y, Enany M, Yamamoto T. Molecular characterization of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus isolates in Egypt. Microbiol Res 2010; 165: 152-162.
137. Al-Ghamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al-Rashed RS. Pattern of admission to hospitals during Muslim Pilgrimage (Hajj). Saudi Med J 2003; 24: 1073-1076.
138. Alzeer A, Mashlah A, Fakim N et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J Infect 1998; 36: 303-306.
139. Abubakar I, Gautret P, Brunette GW et al. Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis 2012; 12: 66-74.
140. Memish ZA, Stephens GM, Steffen R, Ahmed QA. Emergence of medicine for mass gatherings: lessons from the Hajj. Lancet Infect Dis 2012; 12: 56-65.